Cardiovascular Trials in Long-Term Survivors of Childhood Cancer
- 1 March 2004
- journal article
- editorial
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 22 (5), 769-773
- https://doi.org/10.1200/jco.2004.12.937
Abstract
No abstract availableThis publication has 48 references indexed in Scilit:
- Enalapril to Prevent Cardiac Function Decline in Long-Term Survivors of Pediatric Cancer Exposed to AnthracyclinesJournal of Clinical Oncology, 2004
- In Reply:Journal of Clinical Oncology, 2003
- Treatment for Asymptomatic Anthracycline-Induced Cardiac Dysfunction in Childhood Cancer Survivors: The Need for EvidenceJournal of Clinical Oncology, 2003
- Radiation-associated cardiovascular disease: manifestations and managementSeminars in Radiation Oncology, 2003
- Mechanisms of exercise training in patients with heart failureAmerican Heart Journal, 2003
- Preservation of exercise capacity and lack of peripheral changes in asymptomatic patients with severely impaired left ventricular functionEuropean Heart Journal, 2001
- Surrogate end points in cardiovascular disease trialsAmerican Heart Journal, 2000
- Enhanced atherosclerosis and kidney dysfunction in eNOS–/–Apoe–/– mice are ameliorated by enalapril treatmentJCI Insight, 2000
- Anthracycline-induced cardiotoxicity in children and young adultsCritical Reviews in Oncology/Hematology, 1998
- IntroductionAmerican Heart Journal, 1993